Bilaketaren emaitzak - Rudolf M. Huber

Findu emaitzak
  1. 1
    Maximal inspiratory mouth pressures (PIMAX) in healthy subjects—what is the lower limit of normal?

    Maximal inspiratory mouth pressures (PIMAX) in healthy subjects—what is the lower limit of normal? nork Hŭbert Haŭtmann, S. HEFELE, K. Schotten, Rudolf M. Huber

    Argitaratua 2000
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  2. 2
    Place of cryotherapy, brachytherapy and photodynamic therapy in therapeutic bronchoscopy of lung cancers

    Place of cryotherapy, brachytherapy and photodynamic therapy in therapeutic bronchoscopy of lung cancers nork J.-M. Vergnon, Rudolf M. Huber, K. Moghissi

    Argitaratua 2006
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  3. 3
    High Frequency Jet Ventilation in Interventional Fiberoptic Bronchoscopy

    High Frequency Jet Ventilation in Interventional Fiberoptic Bronchoscopy nork Hŭbert Haŭtmann, Fernando Gamarra, Markus O. Henke, Stephanie Diehm, Rudolf M. Huber

    Argitaratua 2000
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  4. 4
    Interactions among Lung Cancer Cells, Fibroblasts, and Macrophages in 3D Co-Cultures and the Impact on MMP-1 and VEGF Expression

    Interactions among Lung Cancer Cells, Fibroblasts, and Macrophages in 3D Co-Cultures and the Impact on MMP-1 and VEGF Expression nork Xiaoqing Liu, Rosemarie Kiefl, Claudia C. Roskopf, Fei Tian, Rudolf M. Huber

    Argitaratua 2016
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  5. 5
    Interdisciplinary multimodality management of stage III nonsmall cell lung cancer

    Interdisciplinary multimodality management of stage III nonsmall cell lung cancer nork Rudolf M. Huber, Dirk De Ruysscher, Hans Hoffmann, Simone Reu, Amanda Tufman

    Argitaratua 2019
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  6. 6
    Effect of growth hormone (hGH) replacement therapy on physical work capacity and cardiac and pulmonary function in patients with hGH deficiency acquired in adulthood.

    Effect of growth hormone (hGH) replacement therapy on physical work capacity and cardiac and pulmonary function in patients with hGH deficiency acquired in adulthood. nork Ralf Nass, Rudolf M. Huber, V. Klauss, Otto Müller, Jochen Schopohl, Christian J. Strasburger

    Argitaratua 1995
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  7. 7
    Simultaneous Chemoradiotherapy Compared With Radiotherapy Alone After Induction Chemotherapy in Inoperable Stage IIIA or IIIB Non–Small-Cell Lung Cancer: Study CTRT99/97 by the Bronchial Carcinoma Therapy Group

    Simultaneous Chemoradiotherapy Compared With Radiotherapy Alone After Induction Chemotherapy in Inoperable Stage IIIA or IIIB Non–Small-Cell Lung Cancer: Study CTRT99/97 by the Bro... nork Rudolf M. Huber, Michael Flentje, Michael Schmidt, Barbara Pöllinger, H. Gosse, Jochen Willner, Kurt Ulm

    Argitaratua 2006
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  8. 8
    Chronic progressive HIV-1 infection is associated with elevated levels of myeloid-derived suppressor cells

    Chronic progressive HIV-1 infection is associated with elevated levels of myeloid-derived suppressor cells nork Thomas Vollbrecht, Renate Stirner, Amanda Tufman, Julia Roider, Rudolf M. Huber, Johannes R. Bogner, Andreas Lechner, Carole Bourquin, Rika Draenert

    Argitaratua 2012
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  9. 9
    Paradigm shifts in lung cancer as defined in the new IASLC/ATS/ERS lung adenocarcinoma classification

    Paradigm shifts in lung cancer as defined in the new IASLC/ATS/ERS lung adenocarcinoma classification nork William D. Travis, E. Brambilla, Paul Van Schil, Giorgio V. Scagliotti, Rudolf M. Huber, Sculier Jp, Johan Vansteenkiste, Andrew G. Nicholson

    Argitaratua 2011
    Testu osoa Testu osoa
    Editorial
    Gogokoenen artean sartu
    Gorde:
  10. 10
    Uric acid, lung function, physical capacity and exacerbation frequency in patients with COPD: a multi-dimensional approach

    Uric acid, lung function, physical capacity and exacerbation frequency in patients with COPD: a multi-dimensional approach nork Kathrin Kahnert, Peter Alter, Tobias Welte, Rudolf M. Huber, Jürgen Behr, Frank Biertz, Henrik Watz, Robert Bals, Claus Vogelmeier, Rudolf A. Jörres

    Argitaratua 2018
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  11. 11
    The European Respiratory Society and European Society of Thoracic Surgeons clinical guidelines for evaluating fitness for radical treatment (surgery and chemoradiotherapy) in patients with lung cancer

    The European Respiratory Society and European Society of Thoracic Surgeons clinical guidelines for evaluating fitness for radical treatment (surgery and chemoradiotherapy) in patie... nork Alessandro Brunelli, Anne Charloux, Chris T. Bolliger, Gaetano Rocco, Jean‐Paul Sculier, Gonzálo Varela, Marc Licker, Mark K. Ferguson, Corinne Faivre‐Finn, Rudolf M. Huber

    Argitaratua 2009
    Testu osoa Testu osoa
    Editorial
    Gogokoenen artean sartu
    Gorde:
  12. 12
    Efficacy of the Irreversible ErbB Family Blocker Afatinib in Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI)–Pretreated Non–Small-Cell Lung Cancer Patients with Brain Metastases or Leptomeningeal Disease

    Efficacy of the Irreversible ErbB Family Blocker Afatinib in Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI)–Pretreated Non–Small-Cell Lung Cancer Patients... nork Petra Hoffknecht, Amanda Tufman, Thomas Wehler, Theo Pelzer, Rainer Wiewrodt, Martin Schütz, Monika Serke, Jan Stöhlmacher-Williams, Angela Märten, Rudolf M. Huber, N Dickgreber

    Argitaratua 2014
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  13. 13
    Guideline adherence of tumor board recommendations in lung cancer and transfer into clinical practice

    Guideline adherence of tumor board recommendations in lung cancer and transfer into clinical practice nork Julia Walter, Caroline Moeller, Blerina Resuli, Diego Kauffmann‐Guerrero, Farkhad Manapov, Julien Dinkel, Jens Neumann, Julia Kovács, Christian Schneider, Rudolf M. Huber, Amanda Tufman

    Argitaratua 2023
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  14. 14
    Reference Values of Impulse Oscillometric Lung Function Indices in Adults of Advanced Age

    Reference Values of Impulse Oscillometric Lung Function Indices in Adults of Advanced Age nork Holger Schulz, Claudia Flexeder, Jürgen Behr, Margit Heier, Rolf Holle, Rudolf M. Huber, Rudolf A. Jörres, Dennis Nowak, Annette Peters, H.‐Erich Wichmann, Joachim Heinrich, Stefan Karrasch

    Argitaratua 2013
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  15. 15
    Systematic Analysis of Self-Reported Comorbidities in Large Cohort Studies – A Novel Stepwise Approach by Evaluation of Medication

    Systematic Analysis of Self-Reported Comorbidities in Large Cohort Studies – A Novel Stepwise Approach by Evaluation of Medication nork Tanja Lucke, Ronald Herrera, Margarethe Wacker, Rolf Holle, Frank Biertz, Dennis Nowak, Rudolf M. Huber, Sandra Söhler, Claus Vogelmeier, Joachim H. Ficker, Harald Mückter, Rudolf A. Jörres

    Argitaratua 2016
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  16. 16
    Characteristics and treatment of new-onset arthritis after checkpoint inhibitor therapy

    Characteristics and treatment of new-onset arthritis after checkpoint inhibitor therapy nork Jan Leipe, Lisa Christ, Andreas Arnoldi, Erik Mille, Frank Berger, Markus V. Heppt, Ilana Goldscheider, Diego Kauffmann‐Guerrero, Rudolf M. Huber, Claudia Dechant, Carola Berking, Hendrik Schulze‐Koops, Alla Skapenko

    Argitaratua 2018
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  17. 17
    Screening for Lung Cancer in Individuals Who Never Smoked: An International Association for the Study of Lung Cancer Early Detection and Screening Committee Report

    Screening for Lung Cancer in Individuals Who Never Smoked: An International Association for the Study of Lung Cancer Early Detection and Screening Committee Report nork Anna Kerpel-Fronius, Martin C. Tammemägi, Milena Čavić, Claudia I. Henschke, Long Jiang, Ella A. Kazerooni, Choon‐Taek Lee, Luigi Ventura, Dawei Yang, Stephen Lam, Rudolf M. Huber, Dawei Yang, Javier J. Zulueta, Lucía Viola, Anant Mohan, Choon‐Taek Lee, Milena Čavić, Heidi Schmidt, Ella A. Kazerooni, Ricardo Sales dos Santos, Anna Kerpel-Fronius, Claudia I. Henschke, Luigi Ventura, Long Jiang, Gabriella Sozzi, Martin C. Tammemägi, Stephen Lam, Rudolf M. Huber

    Argitaratua 2021
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  18. 18
    Interleukin-22 Is Frequently Expressed in Small- and Large-Cell Lung Cancer and Promotes Growth in Chemotherapy-Resistant Cancer Cells

    Interleukin-22 Is Frequently Expressed in Small- and Large-Cell Lung Cancer and Promotes Growth in Chemotherapy-Resistant Cancer Cells nork Sebastian Kobold, Stefanie Völk, Till S. Clauditz, Natascha Jennifer Küpper, Sarah Minner, Amanda Tufman, P Düwell, Michael Lindner, Ina Koch, Simon Heidegger, Simon Rothenfußer, Max Schnurr, Rudolf M. Huber, Waldemar Wilczak, Stefan Endres

    Argitaratua 2013
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  19. 19
    Topotecan/Cisplatin Compared with Cisplatin/Etoposide as First-Line Treatment for Patients with Extensive Disease Small-Cell Lung Cancer: Final Results of a Randomized Phase III Trial

    Topotecan/Cisplatin Compared with Cisplatin/Etoposide as First-Line Treatment for Patients with Extensive Disease Small-Cell Lung Cancer: Final Results of a Randomized Phase III Tr... nork Thomas H. Fink, Rudolf M. Huber, David F. Heigener, Corrina Eschbach, Cornelius F. Waller, E.U. Steinhauer, J. Christian Virchow, Frank Eberhardt, H Schweisfurth, Michael Schroeder, T. H. Ittel, Simone Hummler, Norbert Banik, Thomas Bogenrieder, Thomas Acker, M. Wolf

    Argitaratua 2012
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  20. 20
    Heat Shock Protein 70 (Hsp70) Peptide Activated Natural Killer (NK) Cells for the Treatment of Patients with Non-Small Cell Lung Cancer (NSCLC) after Radiochemotherapy (RCTx) – From Preclinical Studies to a Clinical Phase II Trial

    Heat Shock Protein 70 (Hsp70) Peptide Activated Natural Killer (NK) Cells for the Treatment of Patients with Non-Small Cell Lung Cancer (NSCLC) after Radiochemotherapy (RCTx) – Fro... nork Hanno M. Specht, Norbert Ahrens, Christiane Blankenstein, Thomas Duell, Rainer Fietkau, Udo S. Gaipl, Christine Günther, Sophie Günther, Gregor Habl, Hubert Hautmann, Matthias Hautmann, Rudolf M. Huber, M. Molls, Robert Offner, Claus Rödel, Franz Rödel, Martin Schütz, Stephanie E. Combs, Gabriele Multhoff

    Argitaratua 2015
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: